MR Diagnosis of a Pulmonary Embolism: Comparison of P792 and Gd-DOTA for First-Pass Perfusion MRI and Contrast-Enhanced 3D MRA in a Rabbit Model

다국어 초록 (Multilingual Abstract)

Objective: To compare P792 (gadomelitol, a rapid clearance blood pool MR contrast agent) with gadolinium-tetraazacyclododecanetetraacetic acid (Gd- DOTA), a standard extracellular agent, for their suitability to diagnose a pulmonary embolism (PE) during a first-pass perfusion MRI and 3D contrastenhanced (CE) MR angiography (MRA).
Materials and Methods: A perfusion MRI or CE-MRA was performed in a rabbit PE model following the intravenous injection of a single dose of contrast agent. The time course of the pulmonary vascular and parenchymal enhancement was assessed by measuring the signal in the aorta, pulmonary artery, and lung parenchyma as a function of time to determine whether there is a significant difference between the techniques. CE-MRA studies were evaluated by their ability to depict the pulmonary vasculature and following defects between 3 seconds and 15 minutes after a triple dose intravenous injection of the contrast agents.
Results: The P792 and Gd-DOTA were equivalent in their ability to demonstrate PE as perfusion defects on first pass imaging. The signal from P792 was significantly higher in vasculature than that from Gd-DOTA between the first and the tenth minutes after injection. The results suggest that a CE-MRA PE could be reliably diagnosed up to 15 minutes after injection.
Conclusion: P792 is superior to Gd-DOTA for the MR diagnosis of PE.

다국어 초록 (Multilingual Abstract)

Objective: To compare P792 (gadomelitol, a rapid clearance blood pool MR contrast agent) with gadolinium-tetraazacyclododecanetetraacetic acid (Gd- DOTA), a standard extracellular agent, for their suitability to diagnose a pulmonary embolism (PE) during a first-pass perfusion MRI and 3D contrastenhanced (CE) MR angiography (MRA).
Materials and Methods: A perfusion MRI or CE-MRA was performed in a rabbit PE model following the intravenous injection of a single dose of contrast agent. The time course of the pulmonary vascular and parenchymal enhancement was assessed by measuring the signal in the aorta, pulmonary artery, and lung parenchyma as a function of time to determine whether there is a significant difference between the techniques. CE-MRA studies were evaluated by their ability to depict the pulmonary vasculature and following defects between 3 seconds and 15 minutes after a triple dose intravenous injection of the contrast agents.
Results: The P792 and Gd-DOTA were equivalent in their ability to demonstrate PE as perfusion defects on first pass imaging. The signal from P792 was significantly higher in vasculature than that from Gd-DOTA between the first and the tenth minutes after injection. The results suggest that a CE-MRA PE could be reliably diagnosed up to 15 minutes after injection.
Conclusion: P792 is superior to Gd-DOTA for the MR diagnosis of PE.

참고문헌 (Reference)

• 1 The PIOPED Investigators, "Value of the ventilation/perfusion scan in acute pulmonary embolism: result of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)" 263 : 2753-2759, 1990
• 2 Carson JL, "The clinical course of pulmonary embolism" 326 : 1240-1245, 1992
• 3 Pruessmann KP, "SENSE: sensitivity encoding for fast MRI" 42 : 952-962, 1999
• 4 Kluge A, "Realtime MR with TrueFISP for the detection of acute pulmonary embolism: initial clinical experience" 14 : 709-718, 2004
• 5 Hatabu H, "Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI" 42 : 1033-1038, 1999
• 6 Goldhaber SZ, "Pulmonary embolism" 339 : 93-104, 1998
• 7 Port M, "Physicochemical and biological evaluation of P792, a rapid clearance blood pool agent for magnetic resonance imaging" 36 : 445-454, 2001
• 8 Corot C, "Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography" 35 : 213-218, 2000
• 9 Port M, "P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results" 12 : 121-127, 2001
• 10 Ohno Y, "MR angiography with sensitivity encoding (SENSE) for suspected pulmonary embolism: comparison with MDCT and ventilation-perfusion scintigraphy" 183 : 91-98, 2004
• 11 Dirksen MS, "Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs" 227 : 802-808, 2003
• 12 Griswold MA, "Generalized autocalibrating partially parallel acquisitions (GRAPPA)" 47 : 1202-1210, 2002
• 13 Goyen M, "Dynamic 3D MR angiography of the pulmonary arteries in under four seconds" 13 : 372-377, 2001
• 14 Meaney JF, "Diagnosis of pulmonary embolism with magnetic resonance angiography" 336 : 1422-1427, 1997
• 15 Keilholz SD, "Comparison of first-pass Gd-DOTA and FAIRER MR perfusion imaging in a rabbit model of pulmonary embolism" 16 : 168-171, 2002
• 16 Corot C, "Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol" 38 : 311-319, 2003
• 17 Oudkerk M, "Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study" 359 : 1643-1647, 2002
• 18 Barritt DW, "Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial" 1 : 1309-1312, 1960
• 19 Fink C, "3D pulmonary perfusion MRI and MR angiography of pulmonary embolism in pigs after a single injection of a blood pool MR contrast agent" 14 : 1291-1296, 2004